Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Debt & Borrowing

Advik Laboratories Debt & Borrowing

MPS Pharmaa Limited (formerly Advik Laboratories Limited) confirmed it does not fall under the 'Large Corporate' category as of March 31, 2026. This disclosure complies with SEBI's framework for fund raising via debt securities issuance. The company remains exempt from specific debt-sourcing requirements mandated for large corporate entities.

Source

BSE filing, NSE: ADVIKLA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Advik Laboratories Ltd: key numbers

Share price
₹2.08
Market cap
₹3.98 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-1.02 Cr
P/E (TTM)
-3.8×Sector 45.9×
Promoter holding
35.89%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Advik Laboratories Ltd

All →

Other debt & borrowing announcements

All →